296 related articles for article (PubMed ID: 23762130)
1. Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy.
Prasansuklab A; Tencomnao T
Evid Based Complement Alternat Med; 2013; 2013():413808. PubMed ID: 23762130
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.
Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ
J Neurosci; 2008 Nov; 28(48):12877-86. PubMed ID: 19036982
[TBL] [Abstract][Full Text] [Related]
4. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
5. Effects of medicinal plants on Alzheimer's disease and memory deficits.
Akram M; Nawaz A
Neural Regen Res; 2017 Apr; 12(4):660-670. PubMed ID: 28553349
[TBL] [Abstract][Full Text] [Related]
6. Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.
Rao CV; Farooqui M; Asch AS; Yamada HY
Cell Cycle; 2018; 17(19-20):2321-2334. PubMed ID: 30231670
[TBL] [Abstract][Full Text] [Related]
7. Traditional Oriental Medicines and Alzheimer's Disease.
Jeon SG; Song EJ; Lee D; Park J; Nam Y; Kim JI; Moon M
Aging Dis; 2019 Apr; 10(2):307-328. PubMed ID: 31435482
[TBL] [Abstract][Full Text] [Related]
8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
9. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: many failed trials, so where do we go from here?
Reiss AB; Glass AD; Wisniewski T; Wolozin B; Gomolin IH; Pinkhasov A; De Leon J; Stecker MM
J Investig Med; 2020 Aug; 68(6):1135-1140. PubMed ID: 32699179
[TBL] [Abstract][Full Text] [Related]
11. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
12. Advances in the development of vaccines for Alzheimer's disease.
Lambracht-Washington D; Rosenberg RN
Discov Med; 2013 May; 15(84):319-26. PubMed ID: 23725605
[TBL] [Abstract][Full Text] [Related]
13. Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer's Disease.
Wuli W; Tsai ST; Chiou TW; Harn HJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079110
[TBL] [Abstract][Full Text] [Related]
14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
15. [β Amyloid Hypothesis in Alzheimer's Disease:Pathogenesis,Prevention,and Management].
Zhang H; Zheng Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):702-708. PubMed ID: 31699204
[TBL] [Abstract][Full Text] [Related]
16. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
Bates KA; Verdile G; Li QX; Ames D; Hudson P; Masters CL; Martins RN
Mol Psychiatry; 2009 May; 14(5):469-86. PubMed ID: 18794889
[TBL] [Abstract][Full Text] [Related]
17. Beta-amyloid, neuronal death and Alzheimer's disease.
Carter J; Lippa CF
Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
[TBL] [Abstract][Full Text] [Related]
18. Effects of Amyloid Beta Peptide on Neurovascular Cells.
Askarova S; Tsoy A; Shalakhmetova T; Lee JC
Cent Asian J Glob Health; 2012; 1(1):4. PubMed ID: 29755858
[TBL] [Abstract][Full Text] [Related]
19. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
[TBL] [Abstract][Full Text] [Related]
20. From beta amyloid to altered proteostasis in Alzheimer's disease.
Bruni AC; Bernardi L; Gabelli C
Ageing Res Rev; 2020 Dec; 64():101126. PubMed ID: 32683041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
